OA08749A - Vaccines whose characteristic epitope is incorporated into a protein of picornaviruses, in particular of poliovirus. - Google Patents

Vaccines whose characteristic epitope is incorporated into a protein of picornaviruses, in particular of poliovirus.

Info

Publication number
OA08749A
OA08749A OA59402A OA59402A OA08749A OA 08749 A OA08749 A OA 08749A OA 59402 A OA59402 A OA 59402A OA 59402 A OA59402 A OA 59402A OA 08749 A OA08749 A OA 08749A
Authority
OA
OAPI
Prior art keywords
picornaviruses
poliovirus
protein
incorporated
whose characteristic
Prior art date
Application number
OA59402A
Other languages
French (fr)
Inventor
Girard Marc
Wychowski Cyslaw
Martin Annette
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of OA08749A publication Critical patent/OA08749A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
OA59402A 1987-08-07 1988-08-08 Vaccines whose characteristic epitope is incorporated into a protein of picornaviruses, in particular of poliovirus. OA08749A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8711337A FR2619012B1 (en) 1987-08-07 1987-08-07 VACCINES IN WHICH THE CHARACTERISTIC EPITOPE IS INCORPORATED IN A PROTEIN OF PICORNAVIRUS, ESPECIALLY POLIOVIRUS

Publications (1)

Publication Number Publication Date
OA08749A true OA08749A (en) 1989-03-31

Family

ID=9354047

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59402A OA08749A (en) 1987-08-07 1988-08-08 Vaccines whose characteristic epitope is incorporated into a protein of picornaviruses, in particular of poliovirus.

Country Status (11)

Country Link
EP (1) EP0302801B1 (en)
JP (1) JPH01157380A (en)
AR (1) AR242057A1 (en)
AT (1) ATE129288T1 (en)
DE (1) DE3854591D1 (en)
DK (1) DK438288A (en)
FR (1) FR2619012B1 (en)
OA (1) OA08749A (en)
PT (1) PT88219B (en)
WO (1) WO1989001516A1 (en)
ZA (1) ZA885774B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614404A (en) * 1988-06-10 1997-03-25 Theriod Biologics, Incorporated Self-assembled, defective, non-self-propagating lentivirus particles
US5747324A (en) * 1988-06-10 1998-05-05 Therion Biologics Corporation Self-assembled, defective, non-self-propagating lentivirus particles
AU640619B2 (en) * 1988-10-03 1993-09-02 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
CA2055613A1 (en) * 1989-05-31 1990-12-01 Jeffrey W. Almond Poliovirus chimaeras
GB8912496D0 (en) * 1989-05-31 1989-07-19 Medical Res Council Vaccines
JP3034025B2 (en) * 1989-06-01 2000-04-17 アプライド・バイオテクノロジー・インコーポレーテツド Self-assembled deficient non-self-replicating virions
US5817491A (en) * 1990-09-21 1998-10-06 The Regents Of The University Of California VSV G pseusdotyped retroviral vectors
US5512421A (en) * 1991-02-19 1996-04-30 The Regents Of The University Of California Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
DE69131908T3 (en) * 1991-02-19 2008-04-03 Oxford Biomedica (Uk) Ltd. VIRUS PARTICLES WITH A CHANGED HOSTEL
GB9125896D0 (en) * 1991-12-05 1992-02-05 Almond Jeffrey W Bicistronic viruses
EP0702724A1 (en) * 1993-06-03 1996-03-27 Institut Pasteur Mengovirus as a vector for expression of foreign polypeptides
US6071742A (en) 1997-03-05 2000-06-06 Board Of Regents Of The University Of Nebraska Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
WO2000014263A2 (en) * 1998-09-03 2000-03-16 Board Of Regents, The University Of Texas System Recombinant hepatitis a virus (hav), hav variants, hav-based vaccines and methods of producing them
US8494781B2 (en) 2003-06-06 2013-07-23 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
JP4753943B2 (en) 2004-07-13 2011-08-24 ジェン−プローブ・インコーポレーテッド Compositions and methods for detection of hepatitis A virus nucleic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593002A (en) * 1982-01-11 1986-06-03 Salk Institute Biotechnology/Industrial Associates, Inc. Viruses with recombinant surface proteins

Also Published As

Publication number Publication date
DK438288A (en) 1989-04-10
ZA885774B (en) 1989-04-26
PT88219A (en) 1989-06-30
EP0302801A1 (en) 1989-02-08
WO1989001516A1 (en) 1989-02-23
ATE129288T1 (en) 1995-11-15
FR2619012A1 (en) 1989-02-10
DE3854591D1 (en) 1995-11-23
AR242057A1 (en) 1993-02-26
FR2619012B1 (en) 1989-12-22
JPH01157380A (en) 1989-06-20
EP0302801B1 (en) 1995-10-18
PT88219B (en) 1995-09-12
DK438288D0 (en) 1988-08-05

Similar Documents

Publication Publication Date Title
OA08749A (en) Vaccines whose characteristic epitope is incorporated into a protein of picornaviruses, in particular of poliovirus.
LU90911I2 (en) Recombinant antigen comprising the pre-S1 and S sequences of the hepatitis B virus active ingredient of hepacare
DE69228474D1 (en) STABILIZED TREATMENT OF MONOCLONAL HUMAN CLN-IgG ANTIBODIES
KR880011426U (en) String fastener
NO894266D0 (en) CONTRACTING PREPARATIONS AND PROCEDURES FOR THEIR PREPARATION.
NO872712D0 (en) PROCEDURE FOR THE PREPARATION OF CALCIUM PREPARATIONS.
DK165865C (en) Aqueous preparation of 1,2-benzisothiazole-3-one, its preparation and use
NO873993L (en) PROCEDURE FOR PREPARING FLUORIDE AND CALCIUM PREPARATIONS WITH LONG-RELEASE.
NO873906L (en) PREPARATION OF POTETTE GRANULATE.
NO893794D0 (en) PROCEDURE FOR THE PREPARATION OF IMPROVED HYDROLYZEATED PROTEIN.
IT8621280A0 (en) TYPE OF OVERLOCK STITCH AS WELL AS PROCEDURE AND DEVICE FOR ITS PRODUCTION.
NO893143D0 (en) PREPARATION OF CHLORODIOXIDE.
IT1229178B (en) PROCEDURE FOR OBTAINING A MIXTURE OF RIBONUCLEOTIDES.
AU573574B2 (en) Immunogenic deteminants of foot and mouth disease virus
DK642687D0 (en) N, N'-DISUBSTITUTED URINENTS AND PROCEDURES FOR PRODUCING THEREOF
NO890044L (en) PROCEDURE FOR THE PREPARATION OF A COPOLYMER OF TWO ALFA AMINO ACIDS AND THE SAME PREPARED COPOLYMES.
AU2269188A (en) Vaccines whose characteristic epitope is incorporated into a protein of picornavirus, in particular, poliovirus
DE68901141D1 (en) TILTABLE CAVITY POLE.
NO904108L (en) PREPARATION OF 2,6-DIOXYPIPERIDE INGREDIATES.
NO872199D0 (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF ALCOXYALKYL AND ALKYLMERCAPTOALKYL-SUBSTITUTED BENZOFUROISOKINOLINES.
NO881779D0 (en) PREPARATION OF L-PHENYLALANINE BY RECOMBINANT BACTERIA.
DK573085D0 (en) N- (3-CHLOR-1,2,4-OXADIAZOL-5-YL) WATER PREPARATIONS, THEIR PREPARATION AND USE
NO893796L (en) PROCEDURE FOR THE PREPARATION OF IMPROVED HYDROLYZEATED PROTEIN.
NO884921D0 (en) PROCEDURE FOR THE PREPARATION OF PUPPY DISEASE VACCINE.
NO893795D0 (en) PROCEDURE FOR THE PREPARATION OF IMPROVED HYDROLYZEATED PROTEIN.